Elekta AB (publ) EBIT

The latest EBIT for EKTAY is $700M as of July 2026. That compares with $890M in the prior-year period — down 21.3% year over year. That is below the Healthcare sector average of $22B. Investors often review this figure alongside Elekta AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, EKTAY's EBIT moved from $890M to $700M — a 21.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Elekta AB (publ)'s operating scale or balance-sheet position.

Against Healthcare companies, EKTAY currently prints $700M for EBIT, while the sector average sits near $22B. That is roughly 96.9% below the sector mean. Large gaps often invite a closer look at Elekta AB (publ)'s growth, margins, and balance sheet.

A EBIT figure of $700M for EKTAY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $22B. Explore the charts below for those layers of context.

After noting EKTAY's EBIT ($700M), review year-over-year change from $890M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.